A retrospective single center study to evaluate whether diabetic retinopathy can be reversed after aflibercept treatment
Latest Information Update: 01 Feb 2021
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema; Diabetic retinopathy
- Focus Adverse reactions; Therapeutic Use
- 01 Feb 2021 New trial record
- 01 Jan 2021 Results published in the Journal of International Medical Research